Your browser doesn't support javascript.
loading
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.
Natkunam, Yasodha; de Jong, Daphne; Farinha, Pedro; Gaulard, Philippe; Klapper, Wolfram; Rosenwald, Andreas; Sander, Birgitta; Tooze, Reuben; Advani, Ranjana; Burton, Catherine; Gribben, John G; Kersten, Marie-José; Kimby, Eva; Lenz, Georg; Molina, Thierry; Morschhauser, Franck; Scott, David; Sehn, Laurie; Stevens, Wendy; Clear, Andrew; Baia, Maryse; Habi, Abdelmalek; Elsensohn, Mad-Helenie; Langlois-Jacques, Carole; Maucort-Boulch, Delphine; Calaminici, Maria.
Affiliation
  • Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • de Jong D; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Farinha P; BC Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver, Canada.
  • Gaulard P; Department of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France.
  • Klapper W; Institute of Pathology, University of Schleswig-Holstein Kiel, Kiel, Germany.
  • Rosenwald A; Comprehensive Cancer Center Mainfranken, Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Sander B; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Tooze R; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Advani R; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Burton C; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
  • Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, London, UK.
  • Kersten MJ; Department of Haematology, Cancer Center Amsterdam, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
  • Kimby E; Department of Medicine, Division of Hematology, Karolinska Institute, Stockholm, Sweden.
  • Lenz G; Medical Department A for Haematology, Oncology, and Pneumology, University Hospital Münster, Münster, Germany.
  • Molina T; Department of Pathology, Université Paris Cité, AP-HP, Necker and Robert Debre Hospitals, Paris, France.
  • Morschhauser F; Department of Hematology, CHU Lille, Univ. Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.
  • Scott D; BC Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver, Canada.
  • Sehn L; BC Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver, Canada.
  • Stevens W; Department of Hematology, Radboud UMC Nijmegen, Nijmegen, the Netherlands.
  • Clear A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, London, UK.
  • Baia M; Department of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France.
  • Habi A; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Elsensohn MH; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.
  • Langlois-Jacques C; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.
  • Maucort-Boulch D; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.
  • Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, London, UK.
Histopathology ; 82(7): 1105-1111, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36849712
ABSTRACT

AIMS:

Subclassification of large B cell lymphoma (LBCL) is challenging due to the overlap in histopathological, immunophenotypical and genetic data. In particular, the criteria to separate diffuse large B cell lymphoma (DLBCL) and high-grade B cell lymphoma (HGBL) are difficult to apply in practice. The Lunenburg Lymphoma Biomarker Consortium previously reported a cohort of over 5000 LBCL that included fluorescence in-situ hybridisation (FISH) data. This cohort contained 209 cases with MYC rearrangement that were available for a validation study by a panel of eight expert haematopathologists of how various histopathological features are used. METHODS AND

RESULTS:

Digital whole slide images of haematoxylin and eosin-stained sections allowed the pathologists to visually score cases independently as well as participate in virtual joint review conferences. Standardised consensus guidelines were formulated for scoring histopathological features and included overall architecture/growth pattern, presence or absence of a starry-sky pattern, cell size, nuclear pleomorphism, nucleolar prominence and a range of cytological characteristics. Despite the use of consensus guidelines, the results show a high degree of discordance among the eight expert pathologists. Approximately 50% of the cases lacked a majority score, and this discordance spanned all six histopathological features. Moreover, none of the histological variables aided in prediction of MYC single versus double/triple-hit or immunoglobulin-partner FISH-based designations or clinical outcome measures.

CONCLUSIONS:

Our findings indicate that there are no specific conventional morphological parameters that help to subclassify MYC-rearranged LBCL or select cases for FISH analysis, and that incorporation of FISH data is essential for accurate classification and prognostication.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Histopathology Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Histopathology Year: 2023 Type: Article Affiliation country: United States